Early Neuropsychological Adverse Events After Switching From PI/r to Dolutegravir Could Be Related to Hyperthyroidism in Patients Under Levothyroxine

Antiviral Therapy - United Kingdom
doi 10.3851/imp3107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press

Related search

Putting Patients First: How the FDA Could Use Its Existing Powers to Reduce Post-Market Adverse Events

Indiana Health Law Review
2012English

Switching From Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Changes in Serum TSH and T4 Levels After Switching the Levothyroxine Administration Time From Before Breakfast to Before Dinner

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2015English

Early Gastrointestinal Adverse Events of Pelvic Radiotherapy in Iraqi Patients

2019English

Life-Threatening Cardiovascular Adverse Events Related to Pectus Excavatum Surgery

Cardiovascular Disorders and Medicine
2019English

Immune Dysregulation in Cancer Patients Developing Immune-Related Adverse Events

British Journal of Cancer
Cancer ResearchOncology
2018English

HIV Patients' Gastrointestinal Tolerability and Treatment Satisfaction After Switching From Lopinavir/Ritonavir (LPV/r) SGC to Co-Formulated LPV/r Tablets

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Treatment-Related Adverse Events and Response Rate to Immune Checkpoint Inhibition

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy